Next-generation genetically modified foods need better regulation
By Dana Perls,
STAT
| 02. 02. 2017
The apple that never browns wants to change your mind about genetically modified foods.”
That headline in the Washington Post is just one of many shining the spotlight on the next generation of genetically modified organisms (what many are calling GMO 2.0) heading to our supermarkets and restaurants.
Gene-silenced Arctic apples that do not turn brown when exposed to air, even when rotten, will be sold in stores in the Midwest this week. Other products on the way include canola oil extracted from rapeseed that has been modified by gene editing to withstand more pesticides, but which is being marketed as a non-GMO food by its maker; salmon genetically engineered with eel genes to grow faster; and synthetic vanillin excreted from genetically modified yeast, yet marketed as “natural.”
Researchers are tinkering with nature’s DNA in new and potentially problematic ways and without clear regulatory guidance. They can alter a species by editing or deleting genes, turning genes on or off, or even creating completely new DNA sequences on a computer. Some of these new foods will be marketed as “non-GMO” or...
Related Articles
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...